Initial sitagliptin plus metformin demonstrated to be effective in patients with type 2 diabetes

被引：0
|
作者：
不详
机构：
来源：
FORMULARY | 2007年 / 42卷 / 09期
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：562 / 562
页数：1
相关论文
共 50 条
  • [41] Effect of initial combination therapy with sitagliptin, a dipeptidyl peptidase-4 inhibitor, and metformin on glycemic control in patients with type 2 diabetes
    Goldstein, Barry J.
    Feinglos, Mark N.
    Lunceford, Jared K.
    Johnson, Jeremy
    Williams-Herman, Debora E.
    [J]. DIABETES CARE, 2007, 30 (08) : 1979 - 1987
  • [42] Variations in Inflammatory Biomarkers Following the Addition of Sitagliptin in Patients with Type 2 Diabetes not Controlled with Metformin
    Derosa, Giuseppe
    Carbone, Anna
    D'Angelo, Angela
    Querci, Fabrizio
    Fogari, Elena
    Cicero, Arrigo F. G.
    Maffioli, Pamela
    [J]. INTERNAL MEDICINE, 2013, 52 (19) : 2179 - 2187
  • [43] The Addition of Sitagliptin to Metformin and Pioglitazone Therapy Enhances Glycemic Control in Patients with Type 2 Diabetes
    Fonseca, Vivian
    Staels, Bart
    Morgan, Jerry D., II
    Yue Shentu
    Golm, Gregory T.
    Johnson-Levonas, Amy O.
    Kaufman, Keith D.
    Goldstein, Barry J.
    Steinberg, Helmut
    Henry, Robert
    [J]. DIABETES, 2011, 60 : A308 - A308
  • [44] Efficacy and safety of saxagliptin in combination with metformin compared with sitagliptin in combination with metformin in adult patients with type 2 diabetes mellitus
    Scheen, Andre J.
    Charpentier, Guillaume
    Ostgren, Carl Johan
    Hellqvist, Asa
    Gause-Nilsson, Ingrid
    [J]. DIABETES-METABOLISM RESEARCH AND REVIEWS, 2010, 26 (07) : 540 - 549
  • [45] ECONOMIC EVALUATION OF SAXAGLIPTIN IN COMBINATION WITH METFORMIN VERSUS SITAGLIPTIN OR VILDAGLIPTIN IN COMBINATION WITH METFORMIN IN PATIENTS WITH TYPE 2 DIABETES IN RUSSIA
    Krysanov, I
    Tiapkina, M.
    [J]. VALUE IN HEALTH, 2015, 18 (07) : A608 - A608
  • [46] Biphasic insulin aspart 30 plus metformin: an effective combination in type 2 diabetes
    Kvapil, A
    Swatko, A
    Hilberg, C
    Shestakova, A
    [J]. DIABETES OBESITY & METABOLISM, 2006, 8 (01): : 39 - 48
  • [47] Exenatide plus metformin compared with metformin alone on β-cell function in patients with Type 2 diabetes
    Derosa, G.
    Franzetti, I. G.
    Querci, F.
    Carbone, A.
    Ciccarelli, L.
    Piccinni, M. N.
    Fogari, E.
    Maffioli, P.
    [J]. DIABETIC MEDICINE, 2012, 29 (12) : 1515 - 1523
  • [48] Efficacy and safety of canagliflozin, a sodium glucose co-transporter 2 inhibitor, compared with sitagliptin in patients with type 2 diabetes on metformin plus sulphonylurea
    Schernthaner, G.
    Gross, J.
    Fu, M.
    Yee, J.
    Kawaguchi, M.
    Canovatchel, W.
    Meininger, G.
    [J]. DIABETOLOGIA, 2012, 55 : S108 - S108
  • [49] Initial treatment with metformin plus colesevelam provides greater glycaemic control than metformin alone in Hispanic patients with type 2 diabetes mellitus
    Hernandez-Triana, E.
    Garvey, W. T.
    Goldberg, R. B.
    Handelsman, Y.
    Fonseca, V. A.
    Jones, M. R.
    Abby, S. L.
    Markiewicz, M.
    Jin, X.
    Misir, S.
    Nagendran, S.
    Rosenstock, J.
    [J]. DIABETOLOGIA, 2010, 53
  • [50] Initial combination therapy with metformin plus colesevelam improves lipoprotein particles in patients with early type 2 diabetes mellitus
    Goldberg, Ronald B.
    Rosenson, Robert S.
    Hernandez-Triana, Eric
    Misir, Soamnauth
    Jones, Michael R.
    [J]. JOURNAL OF CLINICAL LIPIDOLOGY, 2012, 6 (04) : 318 - 324
12345